METAIRIE, LA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Testosterone therapy has become a topic of growing interest ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...